Report Categories Report Categories

Report Categories

industry Category

All

Total: 7 records, 1 pages

Global Favipiravir Supply, Demand and Key Producers, 2024-2030

date 27 Feb 2024

date Pharma & Healthcare

new_biaoQian Favipiravir

The global Favipiravir market size is expected to reach $ 67 million by 2030, rising at a market growth of -21.1% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Favipiravir Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Favipiravir

According to our (Global Info Research) latest study, the global Favipiravir market size was valued at USD 352.7 million in 2023 and is forecast to a readjusted size of USD 67 million by 2030 with a CAGR of -21.1% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Favipiravir Tablets Supply, Demand and Key Producers, 2024-2030

date 27 Feb 2024

date Pharma & Healthcare

new_biaoQian Favipiravir Tablets

The global Favipiravir Tablets market size is expected to reach $ 2958.2 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Favipiravir Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 06 Jan 2024

date Pharma & Healthcare

new_biaoQian Favipiravir Tablets

According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD 2193.7 million in 2023 and is forecast to a readjusted size of USD 2958.2 million by 2030 with a CAGR of 4.4% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Favipiravir Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Favipiravir

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.

USD3480.00

Add To Cart

Add To Cart

Global Favipiravir Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

new_biaoQian Favipiravir Tablets

According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

Add To Cart

Add To Cart

Global Favipiravir Tablets Supply, Demand and Key Producers, 2023-2029

date 06 Feb 2023

date Pharma & Healthcare

new_biaoQian Favipiravir Tablets

The global Favipiravir Tablets market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 27 Feb 2024

industry Pharma & Healthcare

new_biaoQian Favipiravir

The global Favipiravir market size is expected to reach $ 67 million by 2030, rising at a market growth of -21.1% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Favipiravir

According to our (Global Info Research) latest study, the global Favipiravir market size was valued at USD 352.7 million in 2023 and is forecast to a readjusted size of USD 67 million by 2030 with a CAGR of -21.1% during review period.

USD3480.00

addToCart

Add To Cart

industry 27 Feb 2024

industry Pharma & Healthcare

new_biaoQian Favipiravir Tablets

The global Favipiravir Tablets market size is expected to reach $ 2958.2 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 06 Jan 2024

industry Pharma & Healthcare

new_biaoQian Favipiravir Tablets

According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD 2193.7 million in 2023 and is forecast to a readjusted size of USD 2958.2 million by 2030 with a CAGR of 4.4% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Favipiravir

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.

USD3480.00

addToCart

Add To Cart

industry 27 Feb 2023

industry Pharma & Healthcare

new_biaoQian Favipiravir Tablets

According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

addToCart

Add To Cart

industry 06 Feb 2023

industry Pharma & Healthcare

new_biaoQian Favipiravir Tablets

The global Favipiravir Tablets market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart